← Back to Search

Behavioural Intervention

Combined Aerobic Exercise and Resistance Training (AE + RT) for Mild Cognitive Impairment (SYNERGIC@Hom Trial)

N/A
Waitlist Available
Led By Chris McGibbon, PhD
Research Sponsored by University of New Brunswick
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjective Cognitive Impairment (SCI) Group. Diagnosis of Subjective Cognitive Impairment, in accordance with the COMPASS-ND study2 definition (Table 1).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention at 4 months, and follow-up at 10 months
Awards & highlights

SYNERGIC@Hom Trial Summary

This trial will test the feasibility of delivering exercise and cognitive interventions to older adults at risk for developing Alzheimer's Disease and Related Dementias in the home, as well as assess participants' preferences for these interventions.

Eligible Conditions
  • Mild Cognitive Impairment

SYNERGIC@Hom Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SYNERGIC@Hom Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention at 4 months, and follow-up at 10 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention at 4 months, and follow-up at 10 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Adherence
Intervention Preference
Secondary outcome measures
Adverse Events
Age
Assessment Tolerability
+61 more

SYNERGIC@Hom Trial Design

4Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Exercise Intervention Training and Cognitive Intervention TrainingExperimental Treatment2 Interventions
Combined Aerobic Exercise and Resistance Training (AE + RT) + Cognitive Training (NeuropeakTM)
Group II: Exercise Intervention Training and Control Cognitive TrainingActive Control2 Interventions
Combined Aerobic Exercise and Resistance Training (AE + RT) + Control Cognitive Training of Website Searching and Video Watching (WS+V)
Group III: Control Exercise Training and Cognitive Intervention TrainingActive Control2 Interventions
Control Balance and Toning Exercise Training (BAT) + Cognitive Training (NeuropeakTM)
Group IV: Control Exercise Training and Control Cognitive TrainingPlacebo Group2 Interventions
Control Balance and Toning Exercise Training (BAT) + Control Cognitive Training of Website Searching and Video Watching (WS+V)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training (NeuropeakTM)
2021
N/A
~60
Combined Aerobic Exercise and Resistance Training (AE + RT)
2021
N/A
~60

Find a Location

Who is running the clinical trial?

Western University, CanadaOTHER
238 Previous Clinical Trials
57,122 Total Patients Enrolled
University of Western Ontario, CanadaOTHER
164 Previous Clinical Trials
319,186 Total Patients Enrolled
University of New BrunswickLead Sponsor
22 Previous Clinical Trials
2,498 Total Patients Enrolled

Media Library

Cognitive Training (NeuropeakTM) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04997681 — N/A
Mild Cognitive Impairment Research Study Groups: Exercise Intervention Training and Cognitive Intervention Training, Exercise Intervention Training and Control Cognitive Training, Control Exercise Training and Cognitive Intervention Training, Control Exercise Training and Control Cognitive Training
Mild Cognitive Impairment Clinical Trial 2023: Cognitive Training (NeuropeakTM) Highlights & Side Effects. Trial Name: NCT04997681 — N/A
Cognitive Training (NeuropeakTM) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04997681 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the projected results from this clinical exploration?

"This medical trial's primary goal, which will be tracked for 4 months post-intervention, is to measure patients' preference of the intervention. Secondary objectives include assessing changes in quality of life through a 36-item questionnaire (SF-36), clinical frailty by using a 9 point scale (CFS), and dietary habits via a 14 item survey (MDA-14)."

Answered by AI

How many individuals can participate in this research project?

"Affirmative. The clinicaltrials.gov website verifies that this investigation is actively recruiting participants, which was initially posted on July 28th 2021 and revised lastly on December 7th 2021. 64 individuals are required for the trial to be held at one site."

Answered by AI

Does this evaluation encompass elderly participants over 85 years old?

"In accordance with this clinical trial's inclusion criteria, the age range for participating patients is between 60 and 90 years of age."

Answered by AI

Who would benefit most from participating in this trial?

"This clinical trial is enlisting 64 elderly individuals exhibiting cognitive deterioration, aged between 60 and 90. To be eligible for participation, applicants must satisfy the following criteria: comply with all home-based assessments and other procedures of the clinical trial; possess a Family Physician; have access to email services as well as internet connectivity; reside in a house or an apartment within their local community; employ either a tablet computer device or pc at home; communicate fluently in English and/or French (both written & spoken); move independently over 10 metres using any mobility aid if needed; suffer from Mild cognitive impairment (MCI) or Subjective"

Answered by AI

Are individuals being enrolled in the trial at this present moment?

"Affirmative. Clinicaltrials.gov data indicates that the trial, which was first posted on July 28th 2021 and last revised December 7th 2021 is currently seeking volunteers. 64 patients are needed from a single clinical site."

Answered by AI
~16 spots leftby Mar 2025